The aurora kinase inhibitor, CCT137690, triggered the necroptosis of pancreatic cancer cells by RIPK1, RIPK3, and MLKL, and hindered the growth of in situ pancreatic tumors in mice [50]. Here, MLKL is linked to pancreatic neoplasm.